Login to Your Account



Clinic Roundup


Tuesday, July 16, 2013
• Immunovaccine Inc., of Halifax, Nova Scotia, said Canada's NCIC Clinical Trials Group will sponsor and carry out a Phase II trial of its cancer vaccine, DPX-Survivac in ovarian cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription